Advisers voted unanimously to recommend a third dose of Pfizer’s vaccine in people 65 and older and those at high risk of severe Covid-19

Members of the FDA’s Vaccines and Related Biological Products Advisory Committee also informally advised the FDA to include health care workers or others at high risk of Covid-19 exposure in … Read More

Loading

Follow by Email
Pinterest
LinkedIn
Share